EGFR and neoplasm: We found that the expression of EGFR, TP63 and FST correlates with immune infiltration in the tumor microenvironment, such that their expression is linked not only with the absence of tumor-eliminating T lymphocytes but also with the presence of tumor-promoting myeloid-derived immune-suppressor cells.